Xian-Jun Yu (Xianjun Yu)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 72

Top Topics

Neuroendocrine Tumors

Regulatory T Cells

Signaling Pathway

Top Venues

Cancer communications (London, England)

Cell proliferation

British journal of cancer

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Yalan Lei, Jin Xu, Mingming Xiao, Di Wu, He Xu, Jing Yang, Xiaoqi Mao, Haoqi Pan, Xian-Jun Yu, Xianjun Yu
Pirfenidone alleviates fibrosis by acting on tumour-stroma interplay in pancreatic cancer. British journal of cancer (2024)
Yalan Lei, Jin Xu, Mingming Xiao, Di Wu, He Xu, Jing Yang, Xiaoqi Mao, Haoqi Pan, Xian-Jun Yu, Xianjun Yu
Pirfenidone alleviates fibrosis by acting on tumour-stroma interplay in pancreatic cancer. British journal of cancer 130 (9) (2024)
Yalan Lei, Jin Xu, Mingming Xiao, Di Wu, He Xu, Jing Yang, Xiaoqi Mao, Haoqi Pan, Xian-Jun Yu, Xianjun Yu
Pirfenidone alleviates fibrosis by acting on tumour-stroma interplay in pancreatic cancer. British journal of cancer (2024)
He Xu, Di Wu, Mingming Xiao, Yubin Lei, Yalan Lei, Xian-Jun Yu, Xianjun Yu
PP2A complex disruptor SET prompts widespread hypertranscription of growth-essential genes in the pancreatic cancer cells. Science advances 10 (4) (2024)
He Xu, Di Wu, Mingming Xiao, Yubin Lei, Yalan Lei, Xian-Jun Yu, Xianjun Yu
PP2A complex disruptor SET prompts widespread hypertranscription of growth-essential genes in the pancreatic cancer cells. Science advances 10 (4) (2024)
Hui-Ru Zhang, Tian-Jiao Li, Xian-Jun Yu, Chen Liu, Wei-Ding Wu, Long-Yun Ye, Kai-Zhou Jin
The GFPT2-O-GlcNAcylation-YBX1 axis promotes IL-18 secretion to regulate the tumor immune microenvironment in pancreatic cancer. Cell death & disease 15 (4) (2024)
Hui-Ru Zhang, Tian-Jiao Li, Xian-Jun Yu, Chen Liu, Wei-Ding Wu, Long-Yun Ye, Kai-Zhou Jin
The GFPT2-O-GlcNAcylation-YBX1 axis promotes IL-18 secretion to regulate the tumor immune microenvironment in pancreatic cancer. Cell death & disease 15 (4) (2024)
Hui-Ru Zhang, Tian-Jiao Li, Xian-Jun Yu, Chen Liu, Wei-Ding Wu, Long-Yun Ye, Kai-Zhou Jin
The GFPT2-O-GlcNAcylation-YBX1 axis promotes IL-18 secretion to regulate the tumor immune microenvironment in pancreatic cancer. Cell death & disease 15 (4) (2024)
He Xu, Di Wu, Mingming Xiao, Yubin Lei, Yalan Lei, Xian-Jun Yu, Xianjun Yu
PP2A complex disruptor SET prompts widespread hypertranscription of growth-essential genes in the pancreatic cancer cells. Science advances 10 (4) (2024)
He Xu, Di Wu, Mingming Xiao, Yubin Lei, Yalan Lei, Xian-Jun Yu, Xianjun Yu
PP2A complex disruptor SET prompts widespread hypertranscription of growth-essential genes in the pancreatic cancer cells. Science advances 10 (4) (2024)
Yalan Lei, Jin Xu, Mingming Xiao, Di Wu, He Xu, Jing Yang, Xiaoqi Mao, Haoqi Pan, Xian-Jun Yu, Xianjun Yu
Pirfenidone alleviates fibrosis by acting on tumour-stroma interplay in pancreatic cancer. British journal of cancer 130 (9) (2024)
Yalan Lei, Jin Xu, Mingming Xiao, Di Wu, He Xu, Jing Yang, Xiaoqi Mao, Haoqi Pan, Xian-Jun Yu, Xianjun Yu
Pirfenidone alleviates fibrosis by acting on tumour-stroma interplay in pancreatic cancer. British journal of cancer 130 (9) (2024)
Hui-Ru Zhang, Tian-Jiao Li, Xian-Jun Yu, Chen Liu, Wei-Ding Wu, Long-Yun Ye, Kai-Zhou Jin
The GFPT2-O-GlcNAcylation-YBX1 axis promotes IL-18 secretion to regulate the tumor immune microenvironment in pancreatic cancer. Cell death & disease 15 (4) (2024)
Zeyin Rong, Jin Xu, Jianhui Yang, Wei Wang, Rong Tang, Zifeng Zhang, Zhen Tan, Qingcai Meng, Jie Hua, Jiang Liu, Bo Zhang, Chen Liang, Xian-Jun Yu, Xianjun Yu
CircRREB1 Mediates Metabolic Reprogramming and Stemness Maintenance to Facilitate Pancreatic Ductal Adenocarcinoma Progression. Cancer research (2024)
Yalan Lei, Jin Xu, Mingming Xiao, Di Wu, He Xu, Jing Yang, Xiaoqi Mao, Haoqi Pan, Xian-Jun Yu, Xianjun Yu
Pirfenidone alleviates fibrosis by acting on tumour-stroma interplay in pancreatic cancer. British journal of cancer 130 (9) (2024)
Ting Wang, Qiangsheng Hu, Borui Li, Guixiong Fan, Desheng Jing, Junfeng Xu, Yuheng Hu, Qin Dang, Shunrong Ji, Chenjie Zhou, Qifeng Zhuo, Xiao-Wu Xu, Yi Qin, Xian-Jun Yu, Zheng Li
Transcription factor EB reprograms branched-chain amino acid metabolism and promotes pancreatic cancer progression via transcriptional regulation of BCAT1. Cell proliferation (2024)
Zhiwen Xiao, Huaxiang Xu, Jonathan R Strosberg, Renquan Lu, Xinzhe Zhu, Shengming Deng, Lei Ding, Quanxing Ni, Andrew L Warshaw, Xian-Jun Yu, Guopei Luo
EGFR is a potential therapeutic target for highly glycosylated and aggressive pancreatic neuroendocrine neoplasms. International journal of cancer (2023)
Xuan Zou, Xuan Lin, He Cheng, Yusheng Chen, Ruijie Wang, Mingjian Ma, Yu Liu, Zhengjie Dai, Yesboli Tasiheng, Yu Yan, Qinqin Hou, Fei Ding, Huan Chen, Xian-Jun Yu, Lei Wang, Chen Liu
Characterization of intratumoral tertiary lymphoid structures in pancreatic ductal adenocarcinoma: cellular properties and prognostic significance. Journal for immunotherapy of cancer 11 (6) (2023)
Ting Wang, Zeng Ye, Zheng Li, De-Sheng Jing, Gui-Xiong Fan, Meng-Qi Liu, Qi-Feng Zhuo, Shun-Rong Ji, Xian-Jun Yu, Xiao-Wu Xu, Yi Qin
Lactate-induced protein lactylation: A bridge between epigenetics and metabolic reprogramming in cancer. Cell proliferation (2023)
Junfeng Xu, Zeng Ye, Qifeng Zhuo, Liang Liu, Yi Qin, Xin Llou, Wu-Hu Zhang, Fei Wang, Yan Wang, Desheng Jing, Guixiong Fan, Yue Zhang, Xuemin Chen, Jie Chen, Xiao-Wu Xu, Xian-Jun Yu, Shunrong Ji
MEN1 degradation induced by neddylation and the CUL4B-DCAF7 axis promotes pancreatic neuroendocrine tumor progression. Cancer research (2023)
Saimeng Shi, Duancheng Guo, Longyun Ye, Tianjiao Li, Qing-Lin Fei, Mengxiong Lin, Xian-Jun Yu, Kai-Zhou Jin, Wei-Ding Wu
Knockdown of TACC3 inhibits tumor cell proliferation and increases chemosensitivity in pancreatic cancer. Cell death & disease 14 (11) (2023)
Junfeng Xu, Wuhu Zhang, Xin Lou, Zeng Ye, Yi Qin, Jie Chen, Xiaowu Xu, Xian-Jun Yu, Shunrong Ji
Recent research hotspots in sequencing and the pancreatic neuroendocrine tumor microenvironment. Cancer biology & medicine (2023)
Mingming Xiao, Jin Xu, Wei Wang, Bo Zhang, Jiang Liu, Jialin Li, Hang Xu, Yingjun Zhao, Xian-Jun Yu, Xianjun Yu
Functional significance of cholesterol metabolism in cancer: from threat to treatment. Experimental & molecular medicine (2023)
Xuan Zou, Xuan Lin, He Cheng, Yusheng Chen, Ruijie Wang, Mingjian Ma, Yu Liu, Zhengjie Dai, Yesboli Tasiheng, Yu Yan, Qinqin Hou, Fei Ding, Huan Chen, Xian-Jun Yu, Lei Wang, Chen Liu
Characterization of intratumoral tertiary lymphoid structures in pancreatic ductal adenocarcinoma: cellular properties and prognostic significance. Journal for immunotherapy of cancer 11 (6) (2023)
Jing Yang, Jin Xu, Wei Wang, Bo Zhang, Xian-Jun Yu, Si Shi
Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets. Signal transduction and targeted therapy 8 (1) (2023)
Yunzhen Qian, Yitao Gong, Xuan Zou, Yu Liu, Yusheng Chen, Ruijie Wang, Zhengjie Dai, Yesiboli Tasiheng, Xuan Lin, Xu Wang, Guopei Luo, Xian-Jun Yu, He Cheng, Chen Liu
Aberrant APOBEC3C expression induces characteristic genomic instability in pancreatic ductal adenocarcinoma. Oncogenesis 11 (1) (2022)
Qing Lin, Shangyou Zheng, Xian-Jun Yu, Meifu Chen, Yu Zhou, Quanbo Zhou, Chonghui Hu, Jing Gu, Zhongdong Xu, Lin Wang, Yimin Liu, Qingyu Liu, Min Wang, Guolin Li, He Cheng, Dongkai Zhou, Guodong Liu, Zhiqiang Fu, Yu Long, Yixiong Li, Weilin Wang, Renyi Qin, Zhihua Li, Rufu Chen
Standard pancreatoduodenectomy versus extended pancreatoduodenectomy with modified retroperitoneal nerve resection in patients with pancreatic head cancer: a multicenter randomized controlled trial. Cancer communications (London, England) 43 (2) (2022)
Qing Lin, Shangyou Zheng, Xian-Jun Yu, Meifu Chen, Yu Zhou, Quanbo Zhou, Chonghui Hu, Jing Gu, Zhongdong Xu, Lin Wang, Yimin Liu, Qingyu Liu, Min Wang, Guolin Li, He Cheng, Dongkai Zhou, Guodong Liu, Zhiqiang Fu, Yu Long, Yixiong Li, Weilin Wang, Renyi Qin, Zhihua Li, Rufu Chen
Standard pancreatoduodenectomy versus extended pancreatoduodenectomy with modified retroperitoneal nerve resection in patients with pancreatic head cancer: a multicenter randomized controlled trial. Cancer communications (London, England) 43 (2) (2022)
Yunzhen Qian, Yitao Gong, Yu Liu, Yusheng Chen, Ruijie Wang, Zhengjie Dai, Xuan Zou, Yesiboli Tasiheng, Guopei Luo, Xuan Lin, Xu Wang, He Cheng, Xian-Jun Yu, Chen Liu
Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma. Journal of immunology research 2022 (2022)
Qing Lin, Shangyou Zheng, Xian-Jun Yu, Meifu Chen, Yu Zhou, Quanbo Zhou, Chonghui Hu, Jing Gu, Zhongdong Xu, Lin Wang, Yimin Liu, Qingyu Liu, Min Wang, Guolin Li, He Cheng, Dongkai Zhou, Guodong Liu, Zhiqiang Fu, Yu Long, Yixiong Li, Weilin Wang, Renyi Qin, Zhihua Li, Rufu Chen
Standard pancreatoduodenectomy versus extended pancreatoduodenectomy with modified retroperitoneal nerve resection in patients with pancreatic head cancer: a multicenter randomized controlled trial. Cancer communications (London, England) 43 (2) (2022)
Zengli Fang, Qingcai Meng, Jin Xu, Wei Wang, Bo Zhang, Jiang Liu, Chen Liang, Jie Hua, Yingjun Zhao, Xian-Jun Yu, Xianjun Yu
Signaling pathways in cancer-associated fibroblasts: recent advances and future perspectives. Cancer communications (London, England) (2022)
Zheng Zhang, Shunrong Ji, Qiangsheng Hu, Qifeng Zhuo, Wei Liu, Wenyan Xu, Wensheng Liu, Mengqi Liu, Zeng Ye, Guixiong Fan, Xiaowu Xu, Xian-Jun Yu, Yi Qin
Improved tumor control with antiangiogenic therapy after treatment with gemcitabine and nab-paclitaxel in pancreatic cancer. Clinical and translational medicine 11 (8) (2022)
Qing Lin, Shangyou Zheng, Xian-Jun Yu, Meifu Chen, Yu Zhou, Quanbo Zhou, Chonghui Hu, Jing Gu, Zhongdong Xu, Lin Wang, Yimin Liu, Qingyu Liu, Min Wang, Guolin Li, He Cheng, Dongkai Zhou, Guodong Liu, Zhiqiang Fu, Yu Long, Yixiong Li, Weilin Wang, Renyi Qin, Zhihua Li, Rufu Chen
Standard pancreatoduodenectomy versus extended pancreatoduodenectomy with modified retroperitoneal nerve resection in patients with pancreatic head cancer: a multicenter randomized controlled trial. Cancer communications (London, England) 43 (2) (2022)
Shutao Pan, Tingting Qin, Taoyuan Yin, Xian-Jun Yu, Jing Li, Jun Liu, Wenxing Zhao, Xuemin Chen, Dewei Li, Jianhua Liu, Jingdong Li, Yahui Liu, Feng Zhu, Min Wang, Hang Zhang, Renyi Qin, null null
Laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: study protocol for a multicentre randomised controlled trial. BMJ open 12 (4) (2022)
Zijian Wu, Jin Xu, Chen Liang, Qingcai Meng, Jie Hua, Wei Wang, Bo Zhang, Jiang Liu, Xian-Jun Yu, Xianjun Yu
Emerging roles of the solute carrier family in pancreatic cancer. Clinical and translational medicine 11 (3) (2022)
Xuhui Tong, Rong Tang, Jin Xu, Wei Wang, Yingjun Zhao, Xian-Jun Yu, Si Shi
Liquid-liquid phase separation in tumor biology. Signal transduction and targeted therapy 7 (1) (2022)
Qing Lin, Shangyou Zheng, Xian-Jun Yu, Meifu Chen, Yu Zhou, Quanbo Zhou, Chonghui Hu, Jing Gu, Zhongdong Xu, Lin Wang, Yimin Liu, Qingyu Liu, Min Wang, Guolin Li, He Cheng, Dongkai Zhou, Guodong Liu, Zhiqiang Fu, Yu Long, Yixiong Li, Weilin Wang, Renyi Qin, Zhihua Li, Rufu Chen
Standard pancreatoduodenectomy versus extended pancreatoduodenectomy with modified retroperitoneal nerve resection in patients with pancreatic head cancer: a multicenter randomized controlled trial. Cancer communications (London, England) (2022)
Zhen Tan, Xianjun Yu, Jin Xu, Xiaomeng Liu, Yubin Lei, Bo Zhang, Jie Hua, Qingcai Meng, Wei Wang, Xian-Jun Yu, Chen Liang
RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m 6 A-YTHDF2-dependent manner. Oncogene 41 (20) (2022)
Zijian Wu, Jin Xu, Rong Tang, Wei Wang, Bo Zhang, Xian-Jun Yu, Jiang Liu, Xianjun Yu
The Role of PDGFRA in Predicting Oncological and Immune Characteristics in Pancreatic Ductal Adenocarcinoma. Journal of oncology 2022 (2022)
Qing Lin, Shangyou Zheng, Xian-Jun Yu, Meifu Chen, Yu Zhou, Quanbo Zhou, Chonghui Hu, Jing Gu, Zhongdong Xu, Lin Wang, Yimin Liu, Qingyu Liu, Min Wang, Guolin Li, He Cheng, Dongkai Zhou, Guodong Liu, Zhiqiang Fu, Yu Long, Yixiong Li, Weilin Wang, Renyi Qin, Zhihua Li, Rufu Chen
Standard pancreatoduodenectomy versus extended pancreatoduodenectomy with modified retroperitoneal nerve resection in patients with pancreatic head cancer: a multicenter randomized controlled trial. Cancer communications (London, England) 43 (2) (2022)
Borui Li, Yi Qin, Xian-Jun Yu, Xiao-Wu Xu, Wenyan Yu
Lipid raft involvement in signal transduction in cancer cell survival, cell death and metastasis. Cell proliferation 55 (1) (2021)
Yalan Lei, Rong Tang, Jin Xu, Wei Wang, Bo Zhang, Jiang Liu, Xian-Jun Yu, Si Shi
Applications of single-cell sequencing in cancer research: progress and perspectives. Journal of hematology & oncology 14 (1) (2021)
Wen-Quan Wang, Wu-Hu Zhang, He-Li Gao, Dan Huang, Hua-Xiang Xu, Shuo Li, Tian-Jiao Li, Shuai-Shuai Xu, Hao Li, Jiang Long, Long-Yun Ye, Chun-Tao Wu, Xuan Han, Xiao-Hong Wang, Liang Liu, Xian-Jun Yu
A novel risk factor panel predicts early recurrence in resected pancreatic neuroendocrine tumors. Journal of gastroenterology 56 (4) (2021)
Wu-Hu Zhang, Wen-Quan Wang, Xuan Han, He-Li Gao, Shuai-Shuai Xu, Shuo Li, Tian-Jiao Li, Hua-Xiang Xu, Hao Li, Long-Yun Ye, Xuan Lin, Chun-Tao Wu, Jiang Long, Xian-Jun Yu, Liang Liu
Infiltrating pattern and prognostic value of tertiary lymphoid structures in resected non-functional pancreatic neuroendocrine tumors. Journal for immunotherapy of cancer 8 (2) (2021)
Hao Li, Wang Jiang, Xue-Ni Liu, Li-Yun Yuan, Tian-Jiao Li, Shuo Li, Shuai-Shuai Xu, Wu-Hu Zhang, He-Li Gao, Xuan Han, Wen-Quan Wang, Chun-Tao Wu, Xian-Jun Yu, Hua-Xiang Xu, Liang Liu
TET1 downregulates epithelial-mesenchymal transition and chemoresistance in PDAC by demethylating CHL1 to inhibit the Hedgehog signaling pathway. Oncogene 39 (36) (2020)
Rong Tang, Jin Xu, Bo Zhang, Jiang Liu, Chen Liang, Jie Hua, Qingcai Meng, Xian-Jun Yu, Si Shi
Ferroptosis, necroptosis, and pyroptosis in anticancer immunity. Journal of hematology & oncology 13 (1) (2020)
Zeng Ye, Wensheng Liu, Qifeng Zhuo, Qiangsheng Hu, Mengqi Liu, Qiqing Sun, Zheng Zhang, Guixiong Fan, Wenyan Xu, Shunrong Ji, Xian-Jun Yu, Yi Qin, Xiao-Wu Xu
Ferroptosis: Final destination for cancer? Cell proliferation 53 (3) (2020)
Yitao Gong, Zhiyao Fan, Guopei Luo, Qiuyi Huang, Yunzhen Qian, He Cheng, Kaizhou Jin, Quanxing Ni, Xian-Jun Yu, Chen Liu
Absolute Counts of Peripheral Lymphocyte Subsets Correlate with the Progression-Free Survival and Metastatic Status of Pancreatic Neuroendocrine Tumour Patients. Cancer management and research 12 (2020)
He Cheng, Guopei Luo, Kaizhou Jin, Zhiyao Fan, Qiuyi Huang, Yitao Gong, Jin Xu, Xian-Jun Yu, Chen Liu
Kras mutation correlating with circulating regulatory T cells predicts the prognosis of advanced pancreatic cancer patients. Cancer medicine 9 (6) (2020)
Qiqing Sun, Guixiong Fan, Qifeng Zhuo, Weixing Dai, Zeng Ye, Shunrong Ji, Wenyan Xu, Wensheng Liu, Qiangsheng Hu, Zheng Zhang, Mengqi Liu, Xian-Jun Yu, Xiao-Wu Xu, Yi Qin
Pin1 promotes pancreatic cancer progression and metastasis by activation of NF-κB-IL-18 feedback loop. Cell proliferation 53 (5) (2020)
Si Shi, Jie Hua, Xian-Jun Yu
Oncologic outcomes of minimally invasive versus open distal pancreatectomy for pancreatic neuroendocrine tumors: Randomized controlled trials are needed. Journal of surgical oncology 120 (7) (2019)
Miaoyan Wei, Si Shi, Jie Hua, Jin Xu, Xian-Jun Yu, null null
Simultaneous resection of the primary tumour and liver metastases after conversion chemotherapy versus standard therapy in pancreatic cancer with liver oligometastasis: protocol of a multicentre, prospective, randomised phase III control trial (CSPAC-1). BMJ open 9 (12) (2019)
Mengqi Liu, Shunrong Ji, Wenyan Xu, Wensheng Liu, Yi Qin, Qiangsheng Hu, Qiqing Sun, Zheng Zhang, Xian-Jun Yu, Xiaowu Xu
Laparoscopic pancreaticoduodenectomy: are the best times coming? World journal of surgical oncology 17 (1) (2019)
Shuo Li, Huaxiang Xu, Chuntao Wu, Wenquan Wang, Wei Jin, Heli Gao, Hao Li, Shirong Zhang, Jinzhi Xu, Wuhu Zhang, Shuaishuai Xu, Tianjiao Li, Quanxing Ni, Xian-Jun Yu, Liang Liu
Prognostic value of γ-glutamyltransferase-to-albumin ratio in patients with pancreatic ductal adenocarcinoma following radical surgery. Cancer medicine 8 (2) (2019)
Yi Qin, Qiangsheng Hu, Shunrong Ji, Jin Xu, Weixing Dai, Wensheng Liu, Wenyan Xu, Qiqing Sun, Zheng Zhang, Quanxing Ni, Xian-Jun Yu, Bo Zhang, Xiaowu Xu
Homeodomain-interacting protein kinase 2 suppresses proliferation and aerobic glycolysis via ERK/cMyc axis in pancreatic cancer. Cell proliferation 52 (3) (2019)
Yiyin Zhang, Jin Xu, Jie Hua, Jiang Liu, Chen Liang, Qingcai Meng, Miaoyan Wei, Bo Zhang, Xian-Jun Yu, Si Shi
A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma. Journal for immunotherapy of cancer 7 (1) (2019)
Zhen Tan, Chen Liang, Xian-Jun Yu, Xianjun Yu
The impact of the nodal status and resection margin on the effectiveness of adjuvant chemotherapy for pancreatic cancer: It calls for more careful evaluation. Journal of surgical oncology 120 (6) (2019)
Tianjiao Li, Hao Li, Shuo Li, Shuaishuai Xu, Wuhu Zhang, Heli Gao, Huaxiang Xu, Chuntao Wu, Wenquan Wang, Xian-Jun Yu, Liang Liu
Research progress and design optimization of CAR-T therapy for pancreatic ductal adenocarcinoma. Cancer medicine 8 (11) (2019)
Chen Liang, Si Shi, Yi Qin, Qingcai Meng, Jie Hua, Qiangshen Hu, Shunrong Ji, Bo Zhang, Jin Xu, Xian-Jun Yu
Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer. Gut 69 (5) (2019)
Qiuyi Huang, Haiyang Zhou, Chen Liu, Xian-Jun Yu
ASO Author Reflections: Resection for Metastasis to the Pancreas-Worthwhile for Selected Patients. Annals of surgical oncology 26 (Suppl 3) (2019)
Kun Fan, Zhiyao Fan, He Cheng, Qiuyi Huang, Chao Yang, Kaizhou Jin, Guopei Luo, Xian-Jun Yu, Chen Liu
Hexokinase 2 dimerization and interaction with voltage-dependent anion channel promoted resistance to cell apoptosis induced by gemcitabine in pancreatic cancer. Cancer medicine 8 (13) (2019)
Zhiyao Fan, Kun Fan, Yitao Gong, Qiuyi Huang, Chao Yang, He Cheng, Kaizhou Jin, Quanxing Ni, Xian-Jun Yu, Guopei Luo, Chen Liu
The CRP/Albumin Ratio Predicts Survival And Monitors Chemotherapeutic Effectiveness In Patients With Advanced Pancreatic Cancer. Cancer management and research 11 (2019)
Yi Qin, Qiangsheng Hu, Jin Xu, Shunrong Ji, Weixing Dai, Wensheng Liu, Wenyan Xu, Qiqing Sun, Zheng Zhang, Quanxing Ni, Bo Zhang, Xian-Jun Yu, Xiaowu Xu
PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis. Cell communication and signaling : CCS 17 (1) (2019)
Jie Hua, Si Shi, Xian-Jun Yu
Outcomes of Lymph Node Dissection for Nonmetastatic Pancreatic Neuroendocrine Tumors: To Dissect or Not To Dissect. Annals of surgical oncology 26 (Suppl 3) (2019)
Yu Zhang, Liang Shang, Changsong Qi, Luo-Hai Chen, Wei Wang, Cheng Fang, Meng Qiu, Xing-Yu Feng, Lin Zhou, Meng Zhang, Huang-Ying Tan, Xu-Dong Qiu, Hao Wang, Rong Lin, Qin Zhang, Yu-Jie Zeng, Kai-Zhou Jin, Xian-Jun Yu, Lin Shen, Min-Hu Chen, Jie Li, Le-Ping Li, Jie Chen
Clinicopathological features and prognostic validity of the European Neuroendocrine Tumor Society (ENETS) and American Joint Committee on Cancer (AJCC) 8th staging systems in colonic neuroendocrine neoplasms. Cancer medicine 8 (11) (2019)
Yiyin Zhang, Chao Yang, He Cheng, Zhiyao Fan, Qiuyi Huang, Yu Lu, Kun Fan, Guopei Luo, Kaizhou Jin, Zhengshi Wang, Chen Liu, Xian-Jun Yu
Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions. Journal of hematology & oncology 11 (1) (2018)
Chen Liang, Si Shi, Qingcai Meng, Dingkong Liang, Jie Hua, Yi Qin, Bo Zhang, Jin Xu, Quanxing Ni, Xian-Jun Yu
MiR-29a, targeting caveolin 2 expression, is responsible for limitation of pancreatic cancer metastasis in patients with normal level of serum CA125. International journal of cancer 143 (11) (2018)
Qiangsheng Hu, Yi Qin, Jinfeng Xiang, Wensheng Liu, Wenyan Xu, Qiqing Sun, Shunrong Ji, Jiang Liu, Zheng Zhang, Quanxing Ni, Jin Xu, Xian-Jun Yu, Bo Zhang
dCK negatively regulates the NRF2/ARE axis and ROS production in pancreatic cancer. Cell proliferation 51 (4) (2018)
Changsong Qi, Wei Wang, Ming Lu, Changqing Zeng, Jie Chen, Enxiao Li, Huangying Tan, Wei Wang, Xian-Jun Yu, Qiyun Tang, Jiemin Zhao, Lin Shen, Jie Li
Clinicopathological features and outcome for neuroendocrine neoplasms of gastroesophageal junction: A population-based study. Cancer medicine 7 (9) (2018)
Qingcai Meng, Jin Xu, Chen Liang, Jiang Liu, Jie Hua, Yiyin Zhang, Quanxing Ni, Xianjun Yu, Xian-Jun Yu
GPx1 is involved in the induction of protective autophagy in pancreatic cancer cells in response to glucose deprivation. Cell death & disease 9 (12) (2018)
He Cheng, Chen Liu, Jiahao Jiang, Guopei Luo, Yu Lu, Kaizhou Jin, Meng Guo, Zhenzhen Zhang, Jin Xu, Liang Liu, Quanxing Ni, Xian-Jun Yu
Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients. International journal of cancer 140 (10) (2017)
Chen Liang, Si Shi, Qingcai Meng, Dingkong Liang, Shunrong Ji, Bo Zhang, Yi Qin, Jin Xu, Quanxing Ni, Xian-Jun Yu
Do anti-stroma therapies improve extrinsic resistance to increase the efficacy of gemcitabine in pancreatic cancer? Cellular and molecular life sciences : CMLS 75 (6) (2017)